Cargando…
Distinct binding pattern of EZH2 and JARID2 on RNAs and DNAs in hepatocellular carcinoma development
Hepatocellular carcinoma (HCC) is one of the most malignant cancers worldwide, with high mortality. However, the molecular regulatory mechanisms of liver cancer, especially transcriptional and post-transcriptional mechanisms, should be further studied. Here we used chromatin and cross-linking immuno...
Autores principales: | Wen, Zhili, He, Ke, Zhan, Meixiao, Li, Yong, Liu, Fei, He, Xu, Wei, Yanli, Zhao, Wei, Zhang, Yu, Xue, Yaqiang, Xia, Yong, Wang, Fenfen, Xia, Zhenglin, Xin, Yongjie, Wu, Yeye, Duan, Xiaopeng, Xiao, Jing, Shen, Feng, Feng, Yuliang, Xiang, Guoan, Lu, Ligong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792092/ https://www.ncbi.nlm.nih.gov/pubmed/36578923 http://dx.doi.org/10.3389/fonc.2022.904633 |
Ejemplares similares
-
LncRNA HOXA11‐AS promotes hepatocellular carcinoma progression by repressing miR‐214‐3p
por: Zhan, Meixiao, et al.
Publicado: (2018) -
Nucleosome-binding activities within JARID2 and EZH1 regulate the function of PRC2 on chromatin
por: Son, Jinsook, et al.
Publicado: (2013) -
Inactive yet indispensable: the tale of Jarid2
por: Landeira, David, et al.
Publicado: (2011) -
Jarid2 is essential for the maintenance of tumor initiating cells in bladder cancer
por: Zhu, Xin-Xing, et al.
Publicado: (2017) -
3D‐Epigenomic Regulation of Gene Transcription in Hepatocellular Carcinoma
por: Feng, Yuliang, et al.
Publicado: (2022)